27.09.2017
- In the shifting pharmaceutical landscape, contract manufacturing organizations (CMOs) and big pharma could see significant benefits. The findings of a new A.T. Kearney study can...
02.06.2017
- Laboratory supplies giant Thermo Fisher Scientific announced plans to buy contract development and manufacturing organization (CDMO) Patheon for $35.00 per share in cash. The...
12.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
06.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
08.09.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
15.03.2016
- US contract drug development and manufacturing services provider Patheon has signed a toll production agreement with leading biotechnology company Amgen. The US firms are based at...
07.10.2015
- Interest in the biopharma industry continues to grow, making the development and manufacturing services of the biologic entities for both drug substance and drug product a more...
